FdaApplication

ANDA 206557

Back to search

Identifiers

Properties

PropertyValue
applicant_nameINVAGEN PHARMACEUTICALS INC
application_typeANDA
approval_date2017-11-13

Products (5)

ProductActive ingredientStrengthDosage form
SIMVASTATINSIMVASTATIN10MGTABLET;ORAL
SIMVASTATINSIMVASTATIN40MGTABLET;ORAL
SIMVASTATINSIMVASTATIN20MGTABLET;ORAL
SIMVASTATINSIMVASTATIN5MGTABLET;ORAL
SIMVASTATINSIMVASTATIN80MGTABLET;ORAL

5 products